{
    "nctId": "NCT00398437",
    "briefTitle": "Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer",
    "officialTitle": "Role of Gadolinium Enhanced Brain Magnetic Resonance in the Follow Up of Metastatic Breast Cancer Patients Overexpressing HER2 Neu. A Randomized Prospective Study",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Metastatic Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 96,
    "primaryOutcomeMeasure": "Survival without neurological symptoms due to brain metastasis and/or leptomeningeal involvement",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically confirmed breast cancer\n\n  * Stage IV disease\n* HER2/neu-overexpression (3+ by immunohistochemistry AND/OR gene amplification by fluorescence in situ hybridization)\n* Undergoing treatment with trastuzumab (Herceptin\u00ae) (alone or together with chemotherapy) once weekly or 3 times weekly AND has achieved responding or stable disease for \u2265 12 weeks\n* No CNS metastases (i.e., brain parenchymal lesions and/or leptomeningeal carcinomatosis)\n* No uncontrolled metastatic disease at study entry\n* Hormone receptor status\n\n  * Not specified\n\nPATIENT CHARACTERISTICS:\n\n* Female\n* Menopausal status not specified\n* Karnofsky performance status 70-100%\n* No contraindication to MRI scan\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}